# Single-Ascending Dose Study of JK07 in Subjects With HFpEF

> **NCT05322616** · PHASE1 · WITHDRAWN · sponsor: **Salubris Biotherapeutics Inc**

## Conditions studied

- Heart Failure With Preserved Ejection Fraction

## Interventions

- **DRUG:** JK07
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT05322616
- **Lead sponsor:** Salubris Biotherapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10-21
- **Primary completion:** 2023-05-26
- **Final completion:** 2023-05-26
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2023-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05322616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05322616, "Single-Ascending Dose Study of JK07 in Subjects With HFpEF". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05322616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*